FarmaForce Limited is an ASX-listed contract sales organisation (CSO) offering innovative sales solutions to the Australian healthcare industry.
Since inception in 2014, the company has grown its revenue, clients and staff to become one of the leading CSOs in the growing Australian healthcare sector.
More than just a salesforce, FarmaForce builds direct sales operations for clients to help them reach their business goals, avoiding the expense and management resources required to recruit and train in-house salespeople.
FarmaForce is a member of The iQ Group Global.
The FarmaForce board draws on decades of experience delivering results in the healthcare industry. Together, the directors set the strategy and ensure high levels of success and governance.
George has more than 30 years’ experience providing accounting and business advisory services, and has been Chairman of the board since 2015. George is Principal of Elias Financial Services, an Authorised Representative of Count Financial Limited, and a member of the Australian Institute of Company Directors.
Executive Director & Group CEO
George is Executive Chairman and CEO of The iQ Group Global. Between 1995 and 2005 he founded and led The Bionuclear Group SA as CEO and Chairman, incorporating Antisoma SA, Bionuclear Institute of Diagnosis and Therapy SA, Bionuclear Research and Development SA and Vitalcheck SA.
Con has more than 21 years’ experience in business and investor relations in the wholesale and retail sectors. As a director of iQnovate since its inception, Con has been responsible for executing the company’s investor relations and capital raising strategy.
Executive Director & General Manager
Harry has been General Manager of FarmaForce since 2016 and has more than 25 years’ experience in global executive management roles in healthcare in Australia and Asia. Prior to joining FarmaForce he was CEO of GE Healthcare Australia for more than nine years, as well as a Director of GE Healthcare.